FDA to Authorize Pfizer Covid Vaccine Booster Dose for Older, At-Risk Americans - Bloomberg

People over age 65 and adults at high risk of severe Covid-19 can receive a booster dose of the Pfizer Inc.-BioNTech SE vaccine, the Food and Drug Administration said, opening a new and more controversial phase of the U.S. immunization campaign.
Article Wed, Sep 22, 2021
cover

People over age 65 and adults at high risk of severe Covid-19 can receive a booster dose of the Pfizer Inc.-BioNTech SE vaccine, the Food and Drug Administration said, opening a new and more controversial phase of the U.S. immunization campaign.